Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry

•The GNAQ oncogene stimulates the transcriptional coactivator YAP in uveal melanoma•A Hippo- and PLCβ-independent Rho GTPase signaling circuitry links GNAQ to YAP•YAP is essential for GNAQ-induced uveal melanoma cell proliferation•YAP represents a suitable therapeutic target for melanomas harboring GNAQ mutations

SummaryMutually exclusive activating mutations in the GNAQ and GNA11 oncogenes, encoding heterotrimeric Gαq family members, have been identified in ∼83% and ∼6% of uveal and skin melanomas, respectively. However, the molecular events underlying these GNAQ-driven malignancies are not yet defined, thus limiting the ability to develop cancer-targeted therapies. Here, we focused on the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway that controls organ size. We found that Gαq stimulates YAP through a Trio-Rho/Rac signaling circuitry promoting actin polymerization, independently of phospholipase Cβ and the canonical Hippo pathway. Furthermore, we show that Gαq promotes the YAP-dependent growth of uveal melanoma cells, thereby identifying YAP as a suitable therapeutic target in uveal melanoma, a GNAQ/GNA11-initiated human malignancy.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (206 K)Download as PowerPoint slide